Height Versus Height and Weight Based Spinal Bupivacaine on Maternal Haemodynamics for Elective Cesarean in Short Stature Patients

• Status: Completed
• Trial end date: 2021-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

Doses of intrathecal bupivacaine based on patients either height or height and weight has shown to lower the risk of maternal hypotension with similar quality of anesthesia compared to conventional doses.

In clinical practice there is a tendency of reducing the dose of bupivacaine as either low fixed dose or using the doses based on either height and weight or height (0.06mg/cm) alone in parturient with short stature. However, there is lack of evidence regarding the appropriate dose required in this group of patients. Therefore, our aim is to compare the height versus height and weight based intrathecal bupivacaine dose for elective caesarean on maternal haemodynamics in short stature patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: B.P. Koirala Institute of Health Sciences
• Treatments: Bupivacaine; Fentanyl

Criteria

Inclusion Criteria:

• Women with full-term gestation undergoing planned Caesarean section under spinal anesthesia

• Who provide consent .

• Height less than 150 cm

Exclusion Criteria:

• Patients with height <140 cm,

• Hypertensive disorders of pregnancy,

• Placental disorders,

• Body mass index ≥ 40 kg/m2,

• Diabetes mellitus

• Cardiovascular

• Cerebrovascular

• Hormonal disorder

• Renal disease

• Polyhydramnios

• Known case of bad obstetric history

• Fetal abnormalities

• Baseline systolic blood pressure (SBP) less than 100 mmHg

• Contraindication to spinal anaesthesia

• Allergy to any drug used in the study and

• Those unable to understand and sign the consent form